medical technology

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

Axenoll Life Sciences AG

Medical Technology

Axenoll 3D Printing GmbH develops and implements projects for cellular 3D screen printing of biomaterials for applications in the medical and biotechnological sector.

Learn more

Laxxon Medical AG

Medical Technology

Laxxon Medical AG owns the exclusive global rights for development, production, and commercialization of an innovative new drug delivery system for the controlled release of pharmaceutical actives. This new process is based on a patented 3D printing process.

Learn more

saniva diagnostics GmbH

Medical Technology

Saniva diagnostics GmbH develops Neuromex a screening instrument (hardware and software), based on the Falling-Stick-Test enabling the early-stage detection of neurodegenerative diseases, before clinical manifestation of the disease.

Learn more

Vitruvia AG

Medical Technology

Vitruvia AG is Europe‘s foremost technology company in the healthcare sector of the circular economy. As a supplier of innovative circular systems for highly complex medical devices, particularly in robot-assisted surgery, Vitruvia AG supports hospitals in creating a secure future.

Learn more

Sign up for our media releases

We regularly report on the business development of Xlife Sciences AG and our project companies.